Registered entities
NEWLEAF SYMBIOTICS
Reg. No. 461650895Belgium
Innovation
45 patent families (19 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies, Operations & transport; filing pace steady. Cited 4,185 times.
| Year | Filings |
|---|---|
| 2015 | 7 |
| 2016 | 10 |
| 2017 | 12 |
| 2018 | 8 |
| 2019 | 10 |
| 2020 | 13 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 15 |
| 2024 | 18 |
| 2025 | 25 |
| 2026 | 5 |
Social engagement
Social engagement: 8.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
14 investors on record; lead investors include Otter Capital, Leaps by Bayer, Gullspang Re:food, RockPort Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 50% |
| Private equity | 3 | 21% |
| Other / undisclosed | 4 | 29% |
Recent activity
26 May 2026
Event
NASCAR